![Tobin Schilke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tobin Schilke
No open positions remaining
Profile
Tobin C.
Schilke is Chief Financial Officer at Crinetics Pharmaceuticals, Inc. since 2025.
Formerly, served as Chief Financial Officer at Revance Therapeutics, Inc. from 2018 to 2025, Chief Financial Officer at Achaogen, Inc. from 2016 to 2018, Chief Financial Officer & Executive Director at Roche Products Ltd. from 2012 to 2016, and Director-Commercial Financial Planning & Analysis at Genentech, Inc. from 2012 to 2014.
Education includes undergraduate studies at Lafayette College, graduate studies at the University of California, Berkeley, and an MBA from Johnson Graduate School of Management.
Former positions of Tobin Schilke
| Companies | Position | End |
|---|---|---|
| CRINETICS PHARMACEUTICALS | Director of Finance/CFO | 01/09/2026 |
| REVANCE THERAPEUTICS, INC. | Director of Finance/CFO | 04/02/2025 |
| ACHAOGEN | Director of Finance/CFO | 01/10/2018 |
Roche Products Ltd.
 Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures diagnostic, diabetes and pharmaceutical products | Director of Finance/CFO | 01/06/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/08/2014 |
Education of Tobin Schilke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures diagnostic, diabetes and pharmaceutical products | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
- Stock Market
- Insiders
- Tobin Schilke
